The chemical class known as Swiprosin-2 Activators represents a diverse spectrum of compounds that indirectly engage with the molecular functionality of Swiprosin-2, a protein with roles in cytoskeletal organization and immune cell signaling. The precise molecular mechanisms of Swiprosin-2 within these domains suggest that its activity can be modulated by chemicals that influence cytoskeletal dynamics and calcium signaling. This class includes agents such as calcium ionophores, which raise intracellular calcium concentrations, potentially impacting the protein's calcium-binding activity. Actin-modifying agents, such as cytochalasins, jasplakinolide, and latrunculin, are also key members of this class, altering the cytoskeletal framework with which Swiprosin-2 interacts. These compounds are not unified by a common structure but are rather characterized by their capacity to modulate the biophysical and biochemical pathways that govern the localization and function of Swiprosin-2 within cells.
Each member of the Swiprosin-2 Activators class operates through a distinct but interconnected network of intracellular signals and structural modifications. Compounds like nocodazole, which disrupts microtubule polymerization, and blebbistatin, a myosin II inhibitor, further exemplify the diverse mechanisms by which this class of chemicals can indirectly influence Swiprosin-2 activity. They affect the protein's functional context rather than the protein directly, which can lead to alterations in Swiprosin-2's behavior or expression levels. As such, these activators offer a multi-faceted approach to modulating Swiprosin-2, capitalizing on the intricacy of intracellular signaling and the dynamic nature of the cytoskeletal architecture. By altering the equilibrium of cellular signaling cascades or cytoskeletal integrity, these chemicals collectively exert their influence over Swiprosin-2, resulting in varied outcomes depending on the cell type and the signaling milieu.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Raises intracellular Ca²⁺, possibly promoting Swiprosin-2 interactions with calcium-binding motifs. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin filaments, potentially altering Swiprosin-2's association with the cytoskeleton. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, which might enhance Swiprosin-2's role in actin cytoskeletal organization. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which can modulate actin dynamics and possibly influence Swiprosin-2. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that can alter calcium signaling, indirectly influencing Swiprosin-2 activity. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist, which may influence Swiprosin-2 by altering Ca²⁺/calmodulin-dependent processes. | ||||||
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $240.00 | 29 | |
Disrupts actin polymerization, which could alter Swiprosin-2 associated processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, potentially affecting cytoskeletal organization and Swiprosin-2's role within it. | ||||||